Modality.AI, Inc. was founded in 2018 by CEO David Suendermann-Oeft, PhD, and CTO David Pautler, PhD, experts in AI and signal processing. Modality has pioneered technology for assessing neurological and psychiatric conditions remotely or in clinical settings through AI-powered audio and visual
Signe Gram Sand Receives Best Poster Award August 16, 2025 Congratulations to Signe Gram Sand for receiving the best poster award at the Young Female Researchers in Speech Workshop at Interspeech 2025. Signe is a master’s student in Biomedical Engineering at Aarhus University, specializing in
Modality.AI complies with applicable laws and regulations and maintains a quality management system to support use in regulated clinical research. Its policies include privacy and FCOI policies.
Modality.AI’s multimodal assessment platform turns structured conversations into measures of speech and facial expression for assessing neurological and psychiatric conditions in clinical research.